The SPDR S&P Pharmaceuticals ETF (XPH) closed at $72.81 on August 22, 2026, marking a 0.51% gain over the prior 24-hour period. The move continued a broader upward trend that has characterized the fund's recent trading activity.
Over the past seven days, XPH has advanced 2.64%, while its 30-day performance shows a more substantial gain of 7.03%. The consistent positive momentum across these timeframes points to sustained buying interest in the pharmaceutical sector as represented by the fund.
XPH tracks the S&P Pharmaceuticals Select Industry Index, offering exposure to a range of companies within the pharmaceutical segment of the broader market. Market capitalization data for the fund was not available as of the reporting date.
The 30-day gain of 7.03% reflects a notably strong stretch for XPH, with the shorter-term figures suggesting the momentum remained intact heading into the August 22 session.
